The results revealed that SOX6 could also induce cisplatin resistance of xenograft tumor, but the combined treatment with ABT‐263 could significantly reduce the volumes, sizes, and weights of the cisplatin‐resistant xenograft tumor in mice (Fig. 7G,H and Fig. S13D). Here, SOX6 is linked to neoplasm.